The Biological Basis for ADHD and Medication Treatment Response: Making Sense of the Data for Professionals and Families

Petti, Theodore A.

Friday, October 26, 2012: 8:00 AM-11:00 AM

Chair:

Theodore A. Petti, M.D.

Discussant:

Timothy E. Wilens, M.D.

33.1

Making Sense of Medication Treatment for ADHD: The Parents Medication Guide to Improve Care
Theodore A. Petti, M.D. Robert Wood Johnson School of Medicine and University Behavioral HealthCare, Piscataway, NJ
Philip Shaw, M.D., Ph.D. National Human Genome Research Institute, Bethesda, MD

33.2

Myths, Misinterpretations, and Meanings of the MTA’s Long-term Medication Effects
Peter Jensen, M.D. Mayo Clinic and The REACH Institute, Rochester, MN

33.3

How Long Should Medication Treatment of ADHD Be Extended?
Jan K. Buitelaar, Ph.D. Radboud University Nijmegen Medical Center, Nijmegen Netherlands

33.4

Short-term and Long-term Tolerance to Medication at Different Levels of Analysis: Effects on Global Functioning, Academic Achievement, Laboratory School Performance, and Dopamine Brain Networks
James Swanson, Ph.D. UCI Child Development Center, Irvine, CA
James Waxmonsky, M.D. Florida International University, Miami, FL
William Pelham, Ph.D. Florida International University, Miami, FL

See more of: Symposium